Department of Public Health and Caring Sciences, Child Health and Parenting (CHAP), Uppsala University, Uppsala, Sweden.
Department of Neuroscience, Child and Adolescent Psychiatry, Uppsala University, Uppsala, Sweden.
J Affect Disord. 2019 Nov 1;258:33-41. doi: 10.1016/j.jad.2019.07.077. Epub 2019 Jul 30.
Depression in adolescence is associated with increased healthcare consumption in adulthood, but prior research has not recognized the heterogeneity of depressive disorders. This paper investigated the additional healthcare usage and related costs in mid-adulthood for individuals with adolescent depression, and examined the mediating role of subsequent depression in early adulthood.
This study was based on the Uppsala Longitudinal Adolescent Depression Study, initiated in Sweden in the early 1990s. Depressive disorders were assessed in adolescence (age 16-17) and early adulthood (age 19-30). Healthcare usage and related costs in mid-adulthood (age 31-40) were estimated using nationwide population-based registries. Participants with specific subtypes of adolescent depression (n = 306) were compared with matched non-depressed peers (n = 213).
Women with persistent depressive disorder (PDD) in adolescence utilized significantly more healthcare resources in mid-adulthood. The association was not limited to psychiatric care, and remained after adjustment for individual and parental characteristics. The total additional annual cost for a single age group of females with a history of PDD at a population level was estimated at 3.10 million USD. Depression recurrence in early adulthood mediated the added costs for psychiatric care, but not for somatic care.
Primary health care data were not available, presumably resulting in an underestimation of the true healthcare consumption. Estimates for males had limited precision due to a relatively small male proportion.
On a population level, the additional healthcare costs incurred in mid-adulthood in females with a history of adolescent PDD are considerable. Early treatment and prevention should be prioritized.
青少年时期的抑郁症与成年后增加的医疗保健消费有关,但先前的研究并未认识到抑郁症的异质性。本文研究了青少年抑郁症患者中年时期额外的医疗保健使用情况和相关费用,并探讨了早期成年期后续抑郁症的中介作用。
本研究基于乌普萨拉青少年抑郁症纵向研究,该研究于 20 世纪 90 年代初在瑞典启动。在青少年时期(16-17 岁)和早期成年期(19-30 岁)评估了抑郁障碍。使用全国性的基于人群的登记册估计中年(31-40 岁)的医疗保健使用情况和相关费用。将患有特定青少年抑郁症亚型的患者(n=306)与匹配的非抑郁同龄人(n=213)进行比较。
青少年时期持续抑郁障碍(PDD)的女性在中年时期使用了更多的医疗保健资源。这种关联不仅限于精神科护理,而且在调整了个体和父母特征后仍然存在。在人群水平上,患有 PDD 病史的女性单一年龄组的年总成本估计为 310 万美元。早期成年期的抑郁复发介导了精神科护理的额外费用,但对躯体护理没有影响。
初级保健数据不可用,可能导致真实医疗保健消费的低估。由于男性比例相对较小,因此男性的估计值精度有限。
在人群水平上,有青少年 PDD 病史的女性在中年时期额外的医疗保健费用相当可观。应优先考虑早期治疗和预防。